2645364
SCDFP · Clinical drug packinfluenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension?
influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension is coded as 2645364 in RxNorm.
What is RxNorm code 2645364?
2645364 is the RxNorm identifier for influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2645364?
2645364 is a SCDFP (Clinical drug pack) in RxNorm.
What is the UMLS mapping for 2645364?
2645364 maps to UMLS C5834572.